stoxline Quote Chart Rank Option Currency Glossary
InspireMD, Inc. (NSPR)
2.43  -0.02 (-0.82%)    07-17 16:00
Open: 2.41
High: 2.46
Volume: 15,922
Pre. Close: 2.45
Low: 2.37
Market Cap: 61(M)
Technical analysis
2024-07-17 5:29:13 PM
Short term     
Mid term     
Targets 6-month :  3.03 1-year :  3.23
Resists First :  2.59 Second :  2.76
Pivot price 2.44
Supports First :  2.3 Second :  1.92
MAs MA(5) :  2.44 MA(20) :  2.47
MA(100) :  2.38 MA(250) :  2.76
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  39.8 D(3) :  42.2
RSI RSI(14): 46.3
52-week High :  3.84 Low :  1.8
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ NSPR ] has closed above bottom band by 42.0%. Bollinger Bands are 62.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.48 - 2.5 2.5 - 2.51
Low: 2.32 - 2.35 2.35 - 2.37
Close: 2.39 - 2.45 2.45 - 2.48
Company Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Headline News

Thu, 18 Jul 2024
InspireMD (NYSE:NSPR) versus Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Head-To-Head Analysis - American Banking and Market News

Sat, 13 Jul 2024
InspireMD (NYSE:NSPR) Research Coverage Started at - MarketBeat

Mon, 01 Jul 2024
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million - GlobeNewswire

Tue, 14 May 2024
InspireMD Inc. (NSPR) Q1 2024 Earnings Call Transcript - Seeking Alpha

Sat, 11 May 2024
InspireMD Insiders Enjoying US$133k Appreciation On US$526.5k Investment - Simply Wall St

Thu, 07 Mar 2024
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 25 (M)
Shares Float 9 (M)
Held by Insiders 17.3 (%)
Held by Institutions 48 (%)
Shares Short 58 (K)
Shares Short P.Month 59 (K)
Stock Financials
EPS -0.5
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.5
Profit Margin 0 %
Operating Margin -490.7 %
Return on Assets (ttm) -48.8 %
Return on Equity (ttm) -93.6 %
Qtrly Rev. Growth 22 %
Gross Profit (p.s.) 0
Sales Per Share 0.25
EBITDA (p.s.) -0.95
Qtrly Earnings Growth 0 %
Operating Cash Flow -17 (M)
Levered Free Cash Flow -9 (M)
Stock Valuations
PE Ratio -4.87
PEG Ratio 0
Price to Book value 1.62
Price to Sales 9.46
Price to Cash Flow -3.7
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android